Search for: "Schering Plough Corp" Results 101 - 120 of 154
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2009, 6:01 am
By David Evans Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again. [read post]
30 Jul 2009, 7:02 am
The same Bloomberg article also re-caps the most recent (albeit a bit dated) information about the extent of this ongoing  Fosamax litigation: Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
4 Aug 2009, 1:15 am
Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
26 Nov 2007, 3:06 pm
The October 2007 FDA staff report was prepared in advance of a meeting of an advisory panel of pediatricians later this week being convened to consider the safety of Serevent and Advair (made by GlaxoSmithKline PLC), both of which contain the active ingredient salmeterol, as well as another asthma drug, Foradil (made by Novartis AG and marketed in the U.S. by Schering-Plough Corp.), which contains the active ingredient formoterol. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  Although several Circuit Court decisions have used the so-called “scope of the patent test” when considering whether patent settlement agreements violate the antitrust laws, including the Eleventh Circuit in litigation involving the same K-DUR patent settlement agreement (see Schering-Plough Corp. v. [read post]
3 Sep 2015, 6:36 am
”).As to deference, Defendants cite a non-binding case, Schering-Plough Healthcare Prods., Inc. v. [read post]
5 Mar 2014, 2:46 pm
Schering-Plough Corp., California Supreme Court – existence of “presumption of reliance” in consumer fraud class actions·                     Caldwell v. [read post]
12 Oct 2007, 7:03 am
Schering-Plough Corp., 2006 WL 2546494, at *2 (E.D. [read post]
27 Sep 2009, 12:38 am
Merck, which is set to buy rival Schering-Plough Corp. by the end of the year, won 11 of 16 Vioxx suits at trial before agreeing to settle all claims. [read post]
13 Aug 2009, 9:19 am
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]